SF3B1 MUTATIONS IN MDS-RS ARISE IN MULTIPOTENT HEMOPOETIC STEM CELLS

被引：0
|
作者：
Mortera-Blanco, T. [1 ]
Dimitriou, M. [1 ]
Woll, P. S. [2 ]
Elvarsdottir, E. [1 ]
Karimi, M. [1 ]
Conte, S. [1 ]
Jansson, M. [1 ]
Douagi, I. [1 ]
Papaemmanuil, E. [3 ]
Jacobsen, S. E. [1 ,2 ]
Hellstrom-Lindberg, E. [1 ]
机构：
[1] Karolinska Univ Hosp Huddinge, Ctr Hematol & Regenerat Med, Stockholm, Sweden
[2] Univ Oxford, Weatherall Inst Mol Med, Haematopoiet Stem Cell Biol Lab, Oxford, England
[3] Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S445
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [11] MUTATIONS OF SF3B1 GENE AND ITS SIGNIFICANCE ON PATIENTS WITH MYELODYSPASTIC SYNDROMES (MDS)
    Zemanova, Z.
    Aghova, T.
    Lhotska, H.
    Svobodova, K.
    Hodanova, L.
    Lizcova, L.
    Pavlistova, L.
    Luksikova, K.
    Sotakova, S.
    Minarik, L.
    Stopka, T.
    Jonasova, A.
    LEUKEMIA RESEARCH, 2023, 128
  • [12] MDS-associated SF3B1 mutations enhance proinflammatory gene expression in patient blast cells
    Pollyea, Daniel A.
    Kim, Hyun Min
    Stevens, Brett M.
    Lee, Frank Fang-Yao
    Harris, Chelsea
    Hedin, Brenna R.
    Knapp, Jennifer R.
    O'Connor, Brian P.
    Jordan, Craig T.
    Pietras, Eric M.
    Tan, Aik Choon
    Alper, Scott
    JOURNAL OF LEUKOCYTE BIOLOGY, 2021, 110 (01) : 197 - 205
  • [13] SF3B1 Mutations in Hematological Malignancies
    Cilloni, Daniela
    Itri, Federico
    Bonuomo, Valentina
    Petiti, Jessica
    CANCERS, 2022, 14 (19)
  • [14] TARGETING THE DEFECTIVE COA PATHWAY TO IMPROVE ERYTHROPOIESIS IN SF3B1-MUTANT MDS-RS PATIENTS
    Philippe, C.
    Mian, S.
    Maniati, E.
    Protopapa, P.
    Bergot, T.
    Piganeau, M.
    Nemkov, T.
    Di Bella, D.
    Morales, V.
    Finch, A.
    D'Alessandro, A.
    Bianchi, K.
    Wang, J.
    Gallipoli, P.
    Kordasti, S.
    Kubasch, A. S.
    Cross, M.
    Platzbecker, U.
    Wiseman, D.
    Bonnet, D.
    Bernard, D.
    Gribben, J.
    Rouault-Pierre, K.
    LEUKEMIA RESEARCH, 2023, 128
  • [15] Activation of Autophagy in Models of SF3B1 Mutant MDS
    Visconte, Valeria
    Adema, Vera
    Przychodzen, Bartlomiej P.
    Noe, Allison
    Toth, Rachel
    Hirbawi, Yasmine
    Hirsch, Cassandra M.
    Khouri, Jack
    LeMelle, Elise
    Balasubramanian, Suresh K.
    Carraway, Hetty E.
    Lindner, Daniel
    Advani, Anjali S.
    Rogers, Heesun J.
    Phillips, James G.
    Radivoyevitch, Tomas
    Kelly, Kevin R.
    Nawrocki, Steffan T.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    Carew, Jennifer
    BLOOD, 2017, 130
  • [16] The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS
    Hofman, Isabel Juliana F.
    Mortera-Blanco, Teresa
    Moura, Pedro Luis
    Vestlund, Johanna
    Larsson, Sigita Venckute
    Elvarsdottir, Edda M.
    Walldin, Gunilla
    Tobiasson, Magnus
    Sander, Birgitta
    Dimitriou, Marios
    Jacobsen, Sten-Eirik W.
    Woll, Petter S.
    Jadersten, Martin
    Hellstrom-Lindberg, Eva
    BLOOD ADVANCES, 2022, 6 (16) : 4705 - 4709
  • [17] SF3B1-Mutant Myelodysplastic Syndrome with Ringed Sideroblasts (MDS-RS) at the Single-Cell Level
    Kanagal-Shamanna, Rashmi
    Adema, Vera
    Ma, Feiyang
    Santoni, Andrea
    Yang, Hui
    Ganan-Gomez, Irene
    Thongon, Natthakan
    Montalban-Bravo, Guillermo
    Pellegrini, Matteo
    Bueso-Ramos, Carlos E.
    Garcia-Manero, Guillermo
    Colla, Simona
    BLOOD, 2020, 136
  • [18] Significance of SF3B1 Mutations in Myeloid Neoplasms
    Gajzer, David C.
    Yeung, Cecilia C. S.
    CLINICS IN LABORATORY MEDICINE, 2023, 43 (04) : 597 - 606
  • [19] SF3B1 mutations in chronic lymphocytic leukemia
    Wan, Youzhong
    Wu, Catherine J.
    BLOOD, 2013, 121 (23) : 4627 - 4634
  • [20] The metabolic reprogramming and vulnerability of SF3B1 mutations
    Dalton, W. Brian
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (03)
12345